Opioid Pain Medications · Tylenol 3
Codeine Not Working for Pain? Your Genetics May Be Why
Codeine must be converted to morphine in the liver before it relieves pain, and that conversion depends entirely on CYP2D6, an enzyme that 5 to 10% of people of European descent cannot run effectively.
If codeine isn't doing anything for your pain, you're not imagining it. Codeine is a prodrug. Your body has to convert it into morphine before it can work, and that conversion depends almost entirely on a single liver enzyme encoded by your DNA. For a meaningful slice of the population, the conversion just doesn't happen well enough for codeine to be useful.
5 to 10% of people of European descent are CYP2D6 poor metabolizers who get no useful pain relief from codeine
Common reasons this happens
You may be a genetic poor metabolizer
This is the most important reason codeine fails, and it isn't really a 'common' reason in the usual sense. About 5-10% of people of European descent (and 1-2% of some Asian populations) genetically lack the enzyme needed to convert codeine into morphine. For these people, codeine won't provide useful pain relief at any dose.
The dose may be too low
Codeine is usually prescribed in combination products like Tylenol 3, which contains 30 mg of codeine plus acetaminophen. For people with normal metabolism, that can be enough for mild to moderate pain, but the dose ceiling is capped by the acetaminophen component, not the codeine itself.
Tolerance may have developed
If you've used codeine or other opioids before, you may have built up some tolerance. Your body needs higher doses to get the same pain relief, which often isn't safe or practical with combination products.
The pain type may not respond well to opioids
Neuropathic pain, inflammatory pain, and some kinds of chronic pain don't always respond well to opioids. If your pain is mostly nerve-based or inflammatory, a different medication class is often a better fit.
For poor metabolizers, codeine won't provide useful pain relief at any dose.
How your genetics can play a role
Few common medications are as gene-dependent as codeine. The drug itself doesn't relieve pain. Your liver has to convert it into morphine using the CYP2D6 enzyme, and how fast that happens (or whether it happens at all) is set by your genotype.
| Gene | What it affects |
|---|---|
| CYP2D6 | CYP2D6 converts codeine into its active form, morphine.[1] People carry different numbers of functional copies of this gene, from zero to more than two. People with no functional copies (poor metabolizers) get almost no morphine from codeine. People with extra functional copies (ultrarapid metabolizers) convert codeine to morphine too quickly, which can be dangerous rather than helpful. |
Poor metabolizers effectively cannot use codeine for pain relief because their bodies don't convert it into morphine. No amount of dose adjustment fixes that; they need a different pain medication. Ultrarapid metabolizers have the opposite problem: they convert codeine to morphine so fast that even standard doses can produce dangerously high morphine levels, with a real risk of respiratory depression and overdose. That's why the FDA added a boxed warning for ultrarapid metabolizers,[2] and why codeine is now contraindicated in children under 12. CPIC guidelines recommend avoiding codeine entirely in both poor and ultrarapid metabolizers.[1]
Want to know what your genetics say about how you'll respond to Codeine?
A Gene2Rx report reads your own DNA to show how it may affect your response to Codeine and your other medications.
Find out todayWhen to consider pharmacogenetic testing
If codeine provides zero pain relief at any dose, pharmacogenetic testing can confirm whether you're a poor metabolizer. This is one of the clearest and most actionable pharmacogenetic results in clinical use. Knowing your CYP2D6 status helps with more than codeine; it also affects your response to tramadol, several antidepressants, and tamoxifen. It's a one-time test with lifelong value.
What you can do next
- Tell your doctor that codeine isn't working. Don't try to increase the dose on your own; combination products contain acetaminophen, which can damage your liver at high doses.
- Ask about pharmacogenetic testing to determine your CYP2D6 metabolizer status.
- Talk through alternative pain medications with your doctor. The right option depends on the type and severity of your pain.
- If you're prescribed a different opioid, keep in mind that tramadol also depends on CYP2D6 and may have the same problem.
Related medications
Related guides
- Atomoxetine Not Working? Why Strattera Might Not Be Helping Your ADHD
- Fibromyalgia Medication Not Working? How Genetics Affects Your Treatment Options
- Migraine Medication Not Working? How Genetics Affects Your Treatment
- Pain Medication Not Working? Why Your Body May Process It Differently
- Tamoxifen Not Working? Why Genetics Matters for Breast Cancer Treatment
- Tramadol Not Working for Pain? Genetics May Explain Why
Frequently asked questions
Why would a doctor prescribe codeine if it doesn't work for some people?
Codeine has been used for decades and works well for most people. Until recently, genetic testing before prescribing wasn't common practice. Now that pharmacogenetic testing is more accessible, more doctors are checking CYP2D6 status before prescribing codeine.
If codeine doesn't work for me, will tramadol work?
Probably not. Tramadol is also a prodrug that needs CYP2D6 to convert it into its active form. If you're a CYP2D6 poor metabolizer, tramadol is likely to be ineffective for the same reason as codeine. Your doctor should factor that in when picking an alternative.
How common is it to be a CYP2D6 poor metabolizer?
About 5-10% of people of European descent, 1-2% of people of East Asian descent, and 3-8% of people of African descent are CYP2D6 poor metabolizers. That works out to tens of millions of people worldwide for whom codeine simply won't work.
References
- CPIC. CPIC Guideline for Opioids (Codeine, Tramadol) and CYP2D6, OPRM1, and COMT (2021). cpicpgx.org
- U.S. Food and Drug Administration. Table of Pharmacogenomic Biomarkers in Drug Labeling (2024). fda.gov
- Clinical Pharmacogenetics Implementation Consortium (CPIC). CPIC Guidelines. cpicpgx.org
Disclaimer: This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before making changes to your medication. Never stop or change a medication without medical supervision.